TECHNIQUE OF SENTINAL LYMPHNODE BIOPSY IN BREAST CANCER
Phase 2
- Conditions
- Health Condition 1: null- BREAST CANCER PATIENTS
- Registration Number
- CTRI/2016/02/006592
- Lead Sponsor
- PRINCIPLE INVESTIGATOR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
i.Breast cancer Patient coming to surgical oncology department of st johns medical college
ii.Node negative
iii.Mammography detected nodes who are negative in FNAC
iv.Undergoing MRM and BCS
Exclusion Criteria
i.Node positive
ii.Pregnant women and lactating women
iii.Neoadjuvant treated patients
iv.Previous breast surgery
v.Metastatic breast cancer
vi.Previous history of radiation to breast or axilla
vii.Previous axillary surgery patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method â?¢Standardize the site of methylene blue injection for breast sentinel lymphnode biopsy <br/ ><br>â?¢ <br/ ><br>Timepoint: ONE AND HALF YEARS
- Secondary Outcome Measures
Name Time Method â?¢Find out the most common relations of sentinel node to various structure in axilla. <br/ ><br> <br/ ><br>Timepoint: ONE AND HALF YEARS